Menu

Walgreens Sues Theranos for $140 Million

The drugstore giant is accusing the blood-testing company of breach of contract, although the full details of the suit have not been disclosed.

Nov 10, 2016
Joshua A. Krisch

In another blow to Theranos, the Silicon Valley startup that closed its blood-testing labs and fired hundreds of employees in 2015 following federal investigations into its practices, one of the company’s erstwhile partners, Walgreens, has initiated a $140 million lawsuit, The Wall Street Journal reported. The complaint was filed under seal, so details remain scant, but Walgreens confirmed that a suit against Theranos is pending.

The relationship between Walgreens and Theranos began in 2013, with Walgreens agreeing to use Theranos’s blood-testing technology in 40 of its Arizona locations. When the Theranos probe came to light, Walgreens pulled all 40 testing sites from its locations.

Theranos released a statement on November 8 that vigorously denied any wrongdoing, and placed the blame squarely on the drugstore giant. “Over the years, Walgreens consistently failed to meet its commitments to Theranos,” the startup wrote. “Through its mishandling of our partnership and now this lawsuit, Walgreens has caused Theranos and its investors significant harm.” 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening